Surveillance decision

Surveillance decision

We will update the guideline on metastatic spinal cord compression in adults.

The following table gives an overview of how evidence identified in surveillance might affect each area of the guideline, including any proposed new areas.

Section of the guideline

New evidence identified

Impact

1.1 Service configuration

Cancer networks

Yes

Yes

1.3 Early detection

Early symptoms and signs

Yes

Yes

1.4 Imaging

Choice of imaging modality

Yes

Yes

Routine MRI and early detection

Yes

Yes

1.5 Treatment

Analgesia

Yes

Yes

Radiotherapy

Yes

Yes

Vertebroplasty and kyphoplasty

Yes

Yes

Surgery

Yes

Yes

Mobilisation

Yes

Yes

Corticosteroids

Yes

Yes

Case selection – Age

Yes

Yes

Technical factors of surgery

Yes

Yes

1.6.5 Access to specialist rehabilitation and transition to care at home

Pathways

Yes

Yes

New area

Case selection – The role of scoring systems

Yes

Yes

Reasons for the decision

This section provides a summary of the areas that will be updated and the reasons for the decision to update.

NICE's guideline on metastatic spinal cord compression in adults has not been updated since its publication in 2008. Feedback from topic experts and stakeholders highlighted that, since its publication, there have been advances in the diagnosis and management of metastatic spinal cord compression (MSCC) that are not reflected in the current recommendations. New evidence demonstrates that changes to multiple areas of the guideline are needed. The surveillance review considered published evidence from Cochrane reviews and NIHR Signals. Additionally, stakeholders and topic experts provided additional studies, information and clinical insight. Therefore, the guideline requires updating.


This page was last updated: 07 February 2019